AVITA Medical, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-48.6M | $-61.8M | $-35.4M | $-26.7M | $-26.6M | $-42.0M | $-25.1M | $-12.7M |
| Depreciation & Amortization | $2.3M | $1.1M | $632.0K | $568.0K | $715.0K | $465.0K | $269.0K | $110.0K |
| Depreciation | $1.6M | $1.0M | $597.0K | $510.0K | $606.0K | $346.0K | $269.0K | $110.0K |
| Amortization | $600.0K | $93.0K | $35.0K | $58.0K | $109.0K | $119.0K | $0 | $0 |
| Stock-Based Compensation | $9.5M | $13.5M | $8.4M | $7.0M | $5.7M | $16.5M | $1.9M | $1.4M |
| Net Cash from Operating Activities | $-31.2M | $-48.9M | $-38.0M | $-19.1M | $-25.9M | $-22.7M | $-19.3M | $-13.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $1.0M | $9.2M | $1.4M | $452.0K | $894.0K | $590.0K | $1.0M | $365.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $12.5M | $37.4M | $1.6M | $-19.3M | $-1.2M | $-847.0K | $-1.2M | $-365.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $14.9M | $3.5M | $40.4M | $900.0K | $64.0M | $77.1M | $29.7M | $21.3M |
| Net Change in Cash | $-3.8M | $-8.1M | $4.0M | $-37.5M | $37.1M | $53.5M | $9.4M | $8.1M |
| Free Cash Flow | $-32.2M | $-58.1M | $-39.4M | $-19.5M | $-26.8M | $-23.3M | $-20.3M | $-13.3M |